GEORGE E. DEESE - 22 May 2025 Form 4 Insider Report for FLOWERS FOODS INC (FLO)

Role
Director
Signature
/s/ Stephanie B. Tillman, Agent
Issuer symbol
FLO
Transactions as of
22 May 2025
Net transactions value
$0
Form type
4
Filing time
27 May 2025, 14:41:39 UTC
Previous filing
19 Mar 2025
Next filing
28 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
DEESE GEORGE E Director 1919 FLOWERS CIRCLE, THOMASVILLE /s/ Stephanie B. Tillman, Agent 27 May 2025 0001219534

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FLO Common Stock Options Exercise $0 +6,570 +0.33% $0.000000 1,998,990 22 May 2025 Direct F1
holding FLO Common Stock 50,301 22 May 2025 By Spouse F2
holding FLO Common Stock 13,717 22 May 2025 By IRA
holding FLO Common Stock 334,178 22 May 2025 By Family Trusts F3
holding FLO Common Stock 675,000 22 May 2025 By Family LLC F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FLO Deferred Stock Options Exercise $0 -6,570 -100% $0.000000 0 22 May 2025 Common Stock 6,570 $0.000000 Direct F5, F6, F7
transaction FLO Deferred Stock Award $0 +9,350 $0.000000 9,350 22 May 2025 Common Stock 9,350 $0.000000 Direct F5, F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 22,696 shares held by a revocable trust, for which trust reporting person is the sole beneficiary and trustee.
F2 Beneficial ownership is disclaimed.
F3 Shares held by multiple family trusts, for all of which trusts reporting person is a co-trustee.
F4 Shares held by family LLC, in which reporting person and his spouse are the only voting members.
F5 Granted under the Flowers Foods, Inc. 2014 Omnibus Equity and Incentive Compensation Plan (Amended and Restated Effective May 25, 2023).
F6 In accordance with the terms of the Deferred Shares Agreement for Directors, the deferred shares awarded do not have a conversion or exercise price.
F7 No expiration date.